Grepafloxacin
Edina Avdic, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
No longer manufactured for U.S. or global markets due to QTc prolongation, withdrawn 1999 (due to cardiac events and sudden death)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Acute exacerbation of chronic bronchitis
Chlamydial infection
Community-acquired pneumonia
Gonorrhea
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2024 Unbound Medicine, Inc. All rights reserved